Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-Year follow-up

British Journal of Ophthalmology

Volumn 93, Issue 9, 2009, Pages 1172-1176

  Krema, H ^a,c   Somani, S ^a   Sahgal, A ^b   Xu, W ^a   Heydarian, M ^a   Payne, D ^b   McGowan, H ^a   Michaels, H ^a   Simpson, E R ^a   Laperriere, N ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOROID MELANOMA; ENUCLEATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEOVASCULAR GLAUCOMA; OPTIC DISK; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RADIATION CATARACT; RADIATION DOSE FRACTIONATION; RETINOPATHY; STEREOTACTIC PROCEDURE; STEREOTACTIC RADIOTHERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE; VISUAL ACUITY; CHOROID TUMOR; MELANOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RADIOSURGERY; RETROSPECTIVE STUDY;

CHOROID NEOPLASMS; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 70249093277     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.153429     Document Type: Article

References (25)

1. Emara K, Weisbrod DJ, Shahgal A, et al. Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: preliminary results. Int J Radiat Oncol Biol Phys 2004;59:94-100. (Pubitemid 38501512)
2. Bellman C, Fuss M, Holz FG, et al. Stereotactic radiation therapy for malignant choroidal tumors. Ophthalmology 2000;107:358-365
3. Dieckmann K, Georg D, Bogner J, et al. Optimizing Linac-based stereotactic radiotherapy of uveal melanomas: 7 years' clinical experience. Int J Radiat Oncol Biol Phys 2006;66:47-52. (Pubitemid 44633551)
4. De Potter P, Shields CL, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: Visual acuity and survival outcome. Arch Ophthalmol 1996;114:1357-1365 (Pubitemid 26398721)
5. 106Rh plaques. Graefe's Arch Clin Exp Ophthalmol 1994;232:482-487
6. De Potter P, Shields CL, Shields JA, et al. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol 1994;78:109-114 (Pubitemid 24053135)
7. Lommatstzsch PK, Lommatzsch R. Treatment of juxtapapillary melanomas. Br J Ophthalmol 1991;75:715-717
8. Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea: Visual results after proton beam irradiation. Ophthalmology 1987;94:354-362
9. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V Twelve-year mortality rates and prognostic factors: COMS report No 28. Arch Ophthalmol 2006;124:1684-1693
10. Williams D, Mieler W, Jaffe G, et al. Magnetic resonance imaging of juxtapapillary plaques in cadaver eyes. Br J Ophthalmol 1990;74:43-46 (Pubitemid 20026680)
11. Harbour JW, Murray TG, Byrne SF, et al. Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina 1996;16:129-134
12. Finger PT. Finger's "Slotted" Eye Plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumors. Br J Ophthalmol 2007;91:891-894
13. Char DH, Castro JR, Kroll SM, et al. Five- year follow- up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990;108:209-214 (Pubitemid 20058151)
14. Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol 1998;125:81-89 (Pubitemid 28049037)
15. Gragoudas ES, Seddon JM, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:348-353 (Pubitemid 17056021)
16. Shields CL, Cater J, Shields JA, et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol 2002;120:933-940 (Pubitemid 34755546)
17. Summanen P, Immonen I, Kivela T, et al. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol 1996;80:732-739 (Pubitemid 26334918)
18. Shields CL, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanomas (> or = 8-mm thick) in 354 consecutive patients. Ophthalmology 2002;109:1838-1849.
19. Karlsson UL, Augsburger JJ, Shields JA, et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology 1998;96:382-388
20. Almony A, Breit S, Zhao H, et al. Tilting of radioactive plaques after initial accurate placement for treatment of uveal melanoma. Arch Ophthalmol 2008;126:65-70.
21. Lumbroso L, Levy C, Plancher C, et al. Results of proton beam irradiation for treatment of choroidal melanoma. J Fr Ophtalmol 2002;25:290-297 (Pubitemid 34269812)
22. Roberge D, Nordstorm S, Corriveau C, et al. Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy. Radiother Oncol 2005;74:71-73 (Pubitemid 40430953)
23. Modorati G, Miserocchi E, Galli L, et al. Gamma knife radiosurgery for uveal melanoma: 12 years of experience. Br J Ophthalmol 2009;93:40-44
24. Seddon JM, Grgoudas ES, Albert DM, et al. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 1985;99:282-290
25. Finger PT, Chin K. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol 2007;125:751-756 (Pubitemid 46919735)